Dirithromycin
Dirithromycin (LY237216), a derivative of Erythromycin, is a potent and orally active semi-synthetic macrolide antibiotic. Dirithromycin is active against gram-positive bacteria, Legionella spp., Helicobacter pylori, and Chlamydia trachomatis[1][2].
Product Specifications
CAS Number
62013-04-1
Product Name Alternative
LY237216
UNSPSC
12352005
Hazard Statement
H317
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/dirithromycin.html
Purity
98.0
Solubility
DMSO : 33.33 mg/mL (ultrasonic) |Ethanol : ≥ 50 mg/mL
Smiles
CC1[C@@]([C@](O)([C@H](OC([C@@H]2C)=O)CC)C)([H])O[C@H](COCCOC)N[C@@]1([H])[C@](C[C@@](O)([C@@H]([C@@H](C)[C@]2([H])O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)O[C@@](O[C@H](C)C[C@@H]4N(C)C)([H])[C@@H]4O)C)([H])C
Molecular Formula
C42H78N2O14
Molecular Weight
835.07
Precautions
H317
References & Citations
[1]Wasilewski MM, et, al. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis. J Antimicrob Chemother. 1999 Apr;43 (4) :541-8.|[2]Counter FT, et, al. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin. Antimicrob Agents Chemother. 1991 Jun;35 (6) :1116-26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Macrolide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7042001-01 1 Pair (Sufficient for 5x 96 Well Plates)
AGER Antibody Pair
Sign In for Pricing
View Details MBS7042001-02 5x 1 Pair (Sufficient for 25x 96 Well Plates)
AGER Antibody Pair
Sign In for Pricing
View Details